Balance Sheet
Cash Flow Statement
Change in Account PayablesChange in IntangiblesChange in InventoryGains from Investment SecuritiesNet Debt Issuances and RepaymentsOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mainz Biomed N.V (MYNZ) Cash from Financing Activities: 2022-2023

Historic Cash from Financing Activities for Mainz Biomed N.V (MYNZ) over the last 2 years, with Dec 2023 value amounting to $3.5 million.

  • Mainz Biomed N.V's Cash from Financing Activities rose 3264.74% to $3.5 million in Q4 2023 from the same period last year, while for Dec 2023 it was $14.2 million, marking a year-over-year decrease of 40.58%. This contributed to the annual value of $16.6 million for FY2024, which is 16.68% up from last year.
  • Per Mainz Biomed N.V's latest filing, its Cash from Financing Activities stood at $3.5 million for Q4 2023, which was down 24.13% from $4.6 million recorded in Q3 2023.
  • Over the past 5 years, Mainz Biomed N.V's Cash from Financing Activities peaked at $24.1 million during Q1 2022, and registered a low of -$109,513 during Q4 2022.
  • Moreover, its 2-year median value for Cash from Financing Activities was $2.1 million (2023), whereas its average is $4.8 million.
  • Within the past 5 years, the most significant YoY rise in Mainz Biomed N.V's Cash from Financing Activities was 28,869.50% (2023), while the steepest drop was 96.79% (2023).
  • Mainz Biomed N.V's Cash from Financing Activities (Quarterly) stood at -$109,513 in 2022, then skyrocketed by 3,264.74% to $3.5 million in 2023.
  • Its Cash from Financing Activities was $3.5 million in Q4 2023, compared to $4.6 million in Q3 2023 and $5.4 million in Q2 2023.